Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Leisure, gaming and gambling

Doubleview Gold stock climbs on scandium recovery results plus more daily small cap movers

Access to a potentially significant source of scandium sparked shares of Doubleview Gold Corp Tuesday plus other big percentage movers on news from the small and micro cap space

4:05pm: Satellos Bioscience, FansUnite Entertainment shares end the day sharply higher

Doubleview Gold closed up 2% at $0.52, while FansUnite Entertainment gained 9% to $0.125, Satellos Bioscience finished 29% higher to $0.40, and Datametrex AI ended unchanged at $0.155.

11:55am: Doubleview Gold, Satellos Bioscience shares make big gains

Doubleview Gold Corp (TSX-V:DBG, OTCQB:DBLVF) shares shot up 22% to $0.62 on Tuesday after the mineral resource exploration and development company announced that its first attempt at recovering scandium in a sequential purification process has recovered 56% of scandium in tailings from its Hat copper-gold-cobalt property in the Golden Triangle region of British Columbia, which the company says represents potentially the first major source of scandium in North America.

READ: Doubleview recovers 56% scandium in first attempt at Hat project in British Columbia

As well, shares of FansUnite Entertainment Inc (TSX:FANS, OTCQX:FUNFF) rose 13% to $0.13 as the global online gaming and affiliate business leader said its 2022 revenue soared 364% to a range of C$26.0 million to C$27.3 million.

Satellos Bioscience Inc (TSXV:MSCL) stock, meanwhile, continued to move higher Tuesday, up 36% to $0.42 following a 19% gain on Monday, after the drug discovery company reported results from multiple preclinical studies in a disease model of Duchenne muscular dystrophy, saying the studies showed a significant increase in muscle size and function in mice.

And, Datametrex AI Limited (TSX-V:DM, OTCQB:DTMXF) shares advanced 7% to $0.165 after the technology-focused company with exposure to artificial intelligence (AI) announced that its wholly-owned Artificial Intelligence Nexalogy Environics Inc subsidiary is working towards launching AnalyticsGPT (Analytics Generative Pre-Trained Transformer) to the general public and SMEs (Small Medium Enterprises).

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK